'i4MDS' consortium wins prestigious EHA Innovation Grant

6693 20240614

In a significant development, the International Integrative Innovative Immunology for Myelodysplastic Neoplasms consortium—known as the ‘i4MDS’—has received an esteemed EHA Innovation Grant.

Read more

Please note: This is a test site. Please visit our production site here: https://ehaweb.org.